B. Ndubisi

The prognostic value of HER-2/neu oncogene in cervical cancer.

S. Sanz, S. Masood, L. Lu, 1997, Annals of clinical and laboratory science.

Staging and recurrence of disease in squamous cell carcinoma of the vulva.

J. Sorosky, R. Zaino, R. Mortel, 1995, Gynecologic oncology.

Stage I squamous cell cervical carcinoma in pregnancy: planned delay in therapy awaiting fetal maturity.

N. Mayr, R. Buller, J. Sorosky, 1995, Gynecologic oncology.

Female Genital Schistosomiasis: Case Report and Review of the Literature

S. Masood, Allison Smith, B. Ndubisi, 2004, Southern medical journal.

Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy.

S J Bernstein, L Sanchez-Ramos, B Ndubisi, 2001, American journal of obstetrics and gynecology.

Serum, Pleural Effusion, and Ascites CA-125 Levels in Ovarian Cancer and Nonovarian Benign and Malignant Diseases: A Comparative Study

P. Neven, S. Peacock, N. Urban, 2002 .

HIV-associated primary cervical non-Hodgkin's lymphoma and two other cases of primary pelvic non-Hodgkin's lymphoma.

T. Guthrie, B. Ndubisi, D. Pham, 2003, Gynecologic oncology.

Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.

J. Fiorica, R. Holloway, J. Lapolla, 2002, Gynecologic oncology.

Extended‐field radiation therapy for carcinoma of the cervix

J. Sorosky, R. Mortel, K. Degeest, 1990, Cancer.